SuperSonic Imagine: General Shareholders’ Meeting of March 26, 2021
26 März 2021 - 6:15PM
Business Wire
Regulatory News:
SuperSonic Imagine (Paris:ALSSI) (Euronext: ALSSI, FR0010526814,
PEA-PME eligible), a company that specializes in ultrasound medical
imaging (echography) (the “Company”), announces that its
combined general shareholders’ meeting (both ordinary and
extraordinary), has been held today at the Company’s registered
office (the “Shareholders’ Meeting”).
With the exception of the 5th and 6th resolutions (relating to
related-party agreements submitted for its approval) and the 17th
resolution (relating to the share capital increase reserved for
members of a group savings plan), the Shareholders' General Meeting
adopted all of the other resolutions (ordinary and extraordinary)
submitted to it.
Thus, the Shareholders' General Meeting approved, notably, the
annual and consolidated financial statements for the financial year
2020, the renewal of the directors' mandates as well as the
resolutions relating to the operations of capital reduction to zero
motivated by losses followed by one or more capital increase
operations of a maximum amount of 60 million euros (including the
issue premium) in order to reconstitute the negative equity of the
Company.
* * *
The detailed results of the votes for each resolution are
published on SuperSonic Imagine’s website
(https://www.supersonicimagine.fr).
About SuperSonic Imagine SuperSonic Imagine is a medical
technology company (Medtech) specialized in ultrasound imaging. The
company designs, develops and markets an ultrasound platform whose
exclusive ultrafast technology (UltraFastTM) has given rise to new
imaging methods, which have now become standards in the
non-invasive care path for the characterization of breast, liver or
prostate diseases. The first innovative mode UltraFastTM is
ShearWave® elastography (SWETM), which allows doctors to instantly
visualize and analyze tissue hardness, which is critical
information for the diagnosis of many pathologies. To date, more
than 600 publications have validated the benefits of its
technologies. The latest addition to the Aixplorer® range,
Aixplorer MACH® 30 introduces a new generation of imaging
UltraFastTM allowing the optimization of all innovative imaging
modes: ShearWave PLUS, UltraFast Doppler, Angio PL.U.S, TriVu. With
more than 3,000 ultrasound platforms installed worldwide,
SuperSonic Imagine is present in more than 80 countries and its
main markets are China, the United States and France. The group's
total revenues for the 2020 financial year amounted to €19.2
million. SuperSonic Imagine is a company listed on Euronext Growth
Paris (symbol: ALSSI). For more information, visit
www.supersonicimagine.fr.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210326005397/en/
Contacts – Investor Relations NewCap Thomas Grojean
supersonicimagine@newcap.eu +33 44 71 94 94